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ABSTRACT
CONTEXT AND OBJECTIVE: Transcranial Doppler (TCD) detects stroke risk among children with sickle cell anemia (SCA). Our aim was to evaluate 
TCD findings in patients with different sickle cell disease (SCD) genotypes and correlate the time-averaged maximum mean (TAMM) velocity with 
hematological characteristics. 
DESIGN AND SETTING: Cross-sectional analytical study in the Pediatric Hematology sector, Universidade Federal de São Paulo. 
METHODS:  85 SCD patients of both sexes, aged 2-18 years, were evaluated, divided into: group I (62 patients with SCA/Sß0 thalassemia); and group 
II (23 patients with SC hemoglobinopathy/Sß+ thalassemia). TCD was performed and reviewed by a single investigator using Doppler ultrasonography 
with a 2 MHz transducer, in accordance with the Stroke Prevention Trial in Sickle Cell Anemia (STOP) protocol. The hematological parameters evaluated 
were: hematocrit, hemoglobin, reticulocytes, leukocytes, platelets and fetal hemoglobin. Univariate analysis was performed and Pearson’s coefficient 
was calculated for hematological parameters and TAMM velocities (P < 0.05). 
RESULTS: TAMM velocities were 137 ± 28 and 103 ± 19 cm/s in groups I and II, respectively, and correlated negatively with hematocrit and 
hemoglobin in group I. There was one abnormal result (1.6%) and five conditional results (8.1%) in group I. All results were normal in group II. Middle 
cerebral arteries were the only vessels affected. 
CONCLUSION: There was a low prevalence of abnormal Doppler results in patients with sickle-cell disease. Time-average maximum mean velocity was 
significantly different between the genotypes and correlated with hematological characteristics. 
RESUMO
CONTEXTO E OBJETIVO: Doppler transcraniano (DTC) detecta risco de acidente vascular cerebral (AVC) em crianças com anemia falciforme (AF). O 
objetivo foi avaliar os resultados ao DTC nos diferentes genótipos da doença falciforme (DF) e correlacionar a velocidade média-máxima (VMMáx) 
às características hematológicas.
TIPO DE ESTUDO E LOCAL: Estudo transversal analítico realizado no setor de Hematopediatria da Universidade Federal de São Paulo.
MÉTODOS: 85 pacientes com DF, 2-18 anos, ambos os sexos, foram avaliados e divididos em: grupo I (62 com AF ou Sß0 talassemia); e grupo II 
(23 com hemoglobinopatia SC ou Sß+ talassemia). DTC foi realizado e revisado por um único investigador usando um aparelho de ultrassonografia 
Doppler com transdutor de 2MHz, conforme critérios do protocolo STOP (Stroke Prevention Trial in Sickle Cell Anemia). As variáveis hematológicas 
avaliadas foram: hematócrito, hemoglobina, reticulócitos, leucócitos, plaquetas, hemoglobina fetal. Análise univariada e coeficiente de Pearson 
calculados para parâmetros hematológicos e VMMáx, P < 0,05.
RESULTADOS: As média das VMMáx foram de 137 ± 28 cm/s e 103 ± 19 cm/s nos grupos I e II, respectivamente. Houve correlação negativa da 
VMMáx com hematócrito e hemoglobina no grupo I. Houve um (1,6%) resultado anormal e 5 (8,1%) condicionais no grupo I; no grupo II, todos 
estavam normais. Artérias cerebrais médias foram as únicas acometidas.
CONCLUSÃO: Houve baixa prevalência de resultados anormais ao DTC em pacientes com DF. A VMMáx foi significativamente diferente entre os 
genótipos da DF e apresentou correlação com variáveis hematológicas.
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INTRODUCTION
Sickle cell disease is a hemoglobinopathy characterized by the 
presence of more than 50% hemoglobin S on hemoglobin electropho-
resis. The homozygote SS form is known as sickle cell anemia. Hemo-
globin S can occur in association with other anomalous types of he-
moglobin, and among these are hemoglobin C and thalassemia beta, 
thus forming different genotypes of sickle cell disease: hemoglobin SC 
disease and S-beta thalassemia.1
It has been estimated that more than seven million people have he-
moglobin S in Brazil, and that more than 25,000 to 30,000 people 
have the homozygote form, with more than 3,500 new cases born ev-
ery year.1,2
In the S-beta globin gene, a normal codon (GAG) is replaced by 
another (GTG), thus resulting in exchanging the sixth amino acid 
of the beta globin. This exchange of glutamic acid for valine causes 
polymerization of hemoglobin S, when exposed to media with low 
oxygen tension, which leads to sickling of red blood cells. This vaso-
occlusive process is responsible for most of the clinical manifestations 
of sickle cell disease.3,4
Stroke is one of the most feared clinical complications from this 
disease because of its high morbidity-mortality.5 In children and ad-
olescents, the most common form is ischemic stroke, and around 
5-10% of patients with sickle cell anemia present stroke by the age 
of 20 years.3,5,6 The physiopathology of ischemic stroke differs from 
the mechanisms of the other complications of the disease. In autopsy 
studies, arteriography and other diagnostic methods, it has been ob-
served that ischemic stroke in cases of sickle cell anemia is caused by 
hypertrophy of the intimal layer of the intracranial arteries, with pro-
liferation of fibroblasts and smooth muscle of blood vessels.3,7,8 Tran-
scranial Doppler enables early detection of arterial abnormalities in 
individuals with sickle cell anemia, which is extremely important for 
instituting primary prevention.9-14
The normal blood flow velocities obtained through transcranial 
Doppler are influenced by several factors, of which the main three de-
terminants are the difference in pressure gradient along the vessel, the 
vessel length and cross-sectional area (caliber) and the blood viscosity. 
The hematocrit level and leukocyte and platelet counts influence blood 
viscosity and thus may have a bearing on blood flow velocity.15-20
Adams et al. conducted several studies using transcranial Doppler 
among individuals with sickle cell anemia to demonstrate the useful-
ness of this examination for evaluating stroke risk. They defined nor-
mal blood flow velocity as values of up to 170 cm/s, intermediate values 
as 170 to 200 cm/s and values greater than 200 cm/s as critical, with 
a high risk of developing stroke.8,18,19,21 Among these patients, if they 
had abnormal results from two Doppler examinations, they received a 
transfusion for primary stroke prevention.9 Blood transfusion was used 
because it is highly effective in reducing the risk of recurrence stroke in 
sickle cell anemia.7
The clinical picture of sickle cell disease is very variable, and he-
matocrit levels, leukocyte counts and hemoglobin S and fetal hemo-
globin percentages correlate with the clinical severity of these patients’ 
conditions.22 In this light, and given that these parameters have been 
little studied in relation to other genotypes of sickle cell disease, our 
aim in this study was to evaluate the results from transcranial Doppler 
among patients with sickle cell disease who were being followed at the 
Pediatric Hematology Outpatient Clinic of Universidade Federal de São 
Paulo (Unifesp), correlating the time-averaged maximum mean velocity 
obtained through transcranial Doppler with the different genotypes of 
sickle cell disease and the hematological characteristics.
OBJECTIVE
To evaluate the results from transcranial Doppler among patients 
with sickle cell disease and correlate the time-averaged maximum mean 
velocity obtained through transcranial Doppler with the different geno-
types of sickle cell disease and the hematological characteristics.
METHODS
This was a single-center cross-sectional study on all patients with 
sickle cell disease between the ages of 2 and 18 years who came to the 
Pediatric Hematology Outpatient Clinic of Unifesp in 2004 and 2005.
The inclusion criteria were that the patients needed to have no pre-
vious clinical diagnosis of stroke and no acute crises.
Patients were excluded if they did not cooperate with transcranial 
Doppler examination, if they did not agree to undergo the examina-
tion, if they were using hydroxyurea or if they had received red blood 
cell transfusions over the preceding three months.
This study was approved by the Research Ethics Committee of 
Unifesp (no. 149/03). An informed consent statement was obtained 
from all the adults responsible for the patients participating in the 
study.
All the transcranial Doppler examinations were performed by 
the same professional, who had been trained to perform transcranial 
Doppler (Silva GS), using the Nicolet EME-Companion TC2000 
apparatus with a 2 MHz transducer and following the criteria of the 
STOP (Stroke Prevention Trial in Sickle Cell Anemia) study.9 From 
this examination, the time-averaged maximum mean velocities were 
determined every 2 mm along the following arteries: bilateral in-
ternal carotid arteries, bilateral anterior cerebral arteries, anterior-
middle cerebral artery bifurcations, middle cerebral arteries, bilateral 
posterior cerebral arteries, bilateral vertebral arteries and basilar ar-
tery. The highest value from the right or left middle cerebral arteries, 
bilateral internal carotid arteries or anterior-middle cerebral artery 
bifurcations was taken as the time-averaged maximum mean velocity 
for each patient and was used in the data analysis. When the time-
averaged maximum mean velocity result was conditional or abnor-
mal, the examinations were repeated until two consecutive abnormal 
results were obtained.
The blood tests performed were total hemoglobin and hematocrit 
assays; leukocyte and platelet counts, performed in an electronic coun-
ter (Coulter model Ssr or Coulter model T-890); hemoglobin S assay 
by means of hemoglobin electrophoresis on cellulose acetate with tris-
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EDTA-borate buffer (pH 8.6); and fetal hemoglobin assay, quantified 
by means of alkaline denaturation.
The patients were divided into two groups, in accordance with the 
clinical and hematological differences already recognized in the litera-
ture. One group was composed of patients with the homozygote form 
and Sβ0 thalassemia (group I), and the other was composed of patients 
with SC hemoglobinopathy and Sβ+ thalassemia (group II).
Table 1. Demographic characteristics of the patients with sickle cell 
disease (groups I and II) who underwent transcranial Doppler examination 
Genotypes
Sickle cell disease genotype
SS Sβ0 thal SC Sβ+ thal
n (%) 57 (67.1%) 5 (5.9%) 19 (22.3%) 4 (4.7%)
Group I Group II
n (%) 62 (73%) 23 (27%)
Age* 8 y 11 m ± 4 y 4 m
(2 y 4 m to 17 y 5 m)
7 y 6 m ± 4 y 0 m
(2 y 7 m to 16 y 2 m)
Male sex
n (%)
32 (51.6%) 13 (56.5%)
SS = sickle cell anemia (homozygote); Sβ0 thal = S-beta0 thalassemia; SC = sickle cell hemoglobinopathy; Sβ+ 
thal = S-beta+ thalassemia; n = number of patients; y = years; m = months.
( ) = range of values found; *mean and standard deviation. Student’s t test
Patients
Group I
SS and Sβ0 (n = 62)
Group II
SC and Sβ+ (n = 23)
P
Hb (g/dl)* 8.0 ± 1.1
(5.7-11.4)
10.4 ± 1.1
(7.7-12.0)
P < 0.01
Htc (%)* 23.0 ± 4.0
(16.0-34.0)
31.0 ± 3.0
(23.0-36.0)
P < 0.01
HbF (%)* 13.3 ± 10.0
(0.0-45.9)
4.8 ± 5.7
(0.0-18.7)
P = 0.03
Platelet count 
(x 10-3/mm3)*
462129 ± 162443
(78000-986000)
316435 ± 172510
(97000-787000)
P < 0.01
Leukocyte count 
(x 10-3/mm3)*
14000 ± 4594
(6100-31200)
9765 ± 3072
(5000-15200)
P = 0.03
Reticulocytes (%)* 8.6 ± 6.4
(0.4-28.9)
2.3 ± 1.7
(0.3-6.0)
P < 0.01
TAMM (cm/s)* 137.0 ± 28.0
(85.0-240.0)
103.0 ± 19.0
(83.0-145.0)
P = 0.01
Sβ0 thal = S-beta0 thalassemia; Sβ+ thal = S-beta+ thalassemia; Hb = hemoglobin; Htc = hematocrit; HbF = 
fetal hemoglobin; TAMM = time-averaged maximum mean velocity from transcranial Doppler.
( ) = range of values found; * mean and standard deviation; Student’s t test. Statistical significance: P < 0.05.
Table 2. Comparison between hematological parameters and time-
averaged maximum mean velocity obtained using transcranial Doppler in 
groups I and II
Table 3. Pearson correlation coefficient between mean maximum velocity 
relating to transcranial Doppler and hematological parameters, for groups 
I and II
Pearson coefficient
Hematological parameters Group I
(n = 62)
Group II
(n = 23)
Hematocrit - 0.38* - 0.29
Hemoglobin - 0.32* - 0.24
Reticulocyte percentage 0.09 0.49*
Platelet count Platelet count 0.18
Leukocyte count 0.14 0.22
Hemoglobin S percentage 0.18 0.17
Hemoglobin F percentage - 0.16 - 0.35
Pearson’s correlation coefficient results were classified as follows: Negative value: inverse correlation; Positive 
value: positive correlation; None: 0.00; Weak: between 0.01 and 0.29; Medium: between 0.30 and 0.59; 
Strong: between 0.60 and 0.89; Very strong: between 0.90 and 0.99; and Perfect: 1.00. *Statistical signifi-
cance: P < 0.01.
The results were described through calculations of means and stan-
dard deviations for variables with normal distribution. Hematological 
parameters predictive of time-averaged maximum mean velocities were 
investigated by means of univariate analysis. Pearson’s coefficient was 
calculated to evaluate correlations between the time-averaged maximum 
mean velocity and the hemoglobin S percentage, fetal hemoglobin per-
centage, hemoglobin level, hematocrit percentage, platelet count, leu-
kocyte count and reticulocyte percentage. The Statistical Package for 
the Social Sciences (SPSS) 10.0 software (SPSS Inc., Chicago, United 
States) was used for the statistical analyses. P values < 0.05 were taken to 
be statistically significant.
RESULTS
By the end of the study period, 85 patients with sickle cell disease 
had been evaluated. Group I was composed of 62 patients and group II 
was composed of 23 patients (Table 1). There were no statistically sig-
nificant differences between the groups with regard to age and sex.
We observed statistically significant differences between the two 
groups for all the hematological parameters (Table 2).
Group I presented a negative correlation between the time-averaged 
maximum mean velocity and the hematocrit percentage and between 
the time-averaged maximum mean velocity and the hemoglobin level. 
Group II presented a positive correlation between the time-averaged 
maximum mean velocity and the reticulocyte count and a negative cor-
relation between the time-averaged maximum mean velocity and the fe-
tal hemoglobin percentage (Table 3).
Only one patient in group I presented an abnormal velocity (1.6%). 
This patient with abnormal velocity had a conditional result (190 cm/s) 
in the first transcranial Doppler that was performed and, in the rep-
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Table 4. Frequencies of time-averaged maximum mean velocity result 
categories from transcranial Doppler on two groups of patients with sickle 
cell disease
TAMM results from TCD
Normal
n (%)
Conditional
n (%)
Abnormal
n (%)
Group I (SS and Sβ0) n = 62 55 (90.3) 5 (8.1) 1 (1.6)
Group II (SC and Sβ+) n = 23 23 (100.0) 0 (0.0) 0 (0.0)
TCD = transcranial Doppler; TAMM = time-averaged maximum mean velocity.
normal TAMM: < 170 cm/s; conditional TAMM: between 170 and 200 cm/s; abnormal TAMM: > 200 cm/s.
etitions, presented abnormal velocity in two consecutive examinations 
(time-averaged maximum mean velocities of 220 cm/s and 240 cm/s). 
Five patients (8.1%) in group I presented conditional time-averaged 
maximum mean velocities (Table 4).
It was observed that the arteries affected in these patients were the 
right or left middle cerebral artery in all the cases, both in the patient 
with abnormal and in the patients with conditional time-averaged max-
imum mean velocities.
DISCUSSION
The use of transcranial Doppler has become an important tool for 
stroke prevention among patients with sickle cell anemia. Stroke occurs 
four times more often among sickle cell anemia patients than among pa-
tients with SC hemoglobinopathy or Sβ thalassemia.5
In the STOP study, which was carried out in 1998 and is the big-
gest study on transcranial Doppler in relation to patients with sickle 
cell anemia within the pediatric age group, the proportion of abnor-
mal results was 9.7%.9 Thus, the results differed from those of the 
present study, in which only one patient with a time-averaged maxi-
mum mean velocity greater than 200 cm/s was found, representing 
1.6%. This finding is in agreement with the results from other stud-
ies conducted in Brazil, which also found lower frequencies of abnor-
mal results.23-25 
In Sergipe, in 2005, Melo et al. gathered data on 34 patients with 
sickle cell anemia, aged less than 18 years, and compared them with 80 
controls. Among the results from the patients, none of them (0.0%) 
presented abnormal time-averaged maximum mean velocity and four 
(11.7%) presented conditional results.24
In São Paulo, Park et al. evaluated 77 patients with sickle cell 
disease, aged between 2 and 16 years. They found two patients 
(2.6%) with abnormal time-averaged maximum mean velocity and 
11 (14.3%) with conditional results.23
In Minas Gerais, in 2008, Silva et al. evaluated 153 children 
with sickle cell anemia, aged 2 to 16 years. They found seven patients 
(4.6%) with abnormal time-averaged maximum mean velocity and 16 
(10.4%) with conditional results.25
In 1999, Kinney et al.22 investigated correlations of risk factors 
for stroke among patients with sickle cell anemia and found a posi-
tive correlation with the Senegal haplotype. In Brazil, the most com-
mon haplotype is Bantu, which may be a factor contributing towards 
this difference. The presence of alpha thalassemia, adherence mole-
cules and thrombophilic factors such as hyperhomocysteinemia or fac-
tor V Leiden have been suggested as other likely factors involved in 
stroke risk.22,26-30
Group II did not present any abnormal or conditional result from 
transcranial Doppler, probably because of the lower severity of these 
patients’ condition. So far, there are no data in the literature indicating 
screening for stroke risk using transcranial Doppler among other geno-
types of sickle cell disease. In 1990, Adams et al. evaluated patients with 
sickle cell anemia and SC hemoglobinopathy, although only 10 SC he-
moglobinopathy patients were included in the sample (190 patients) 
and they were analyzed together. In other studies, only patients with 
sickle cell anemia were included.9,10,15,21
In agreement with several other studies, there was a negative corre-
lation in group I between the time-averaged maximum mean velocities 
and the hematocrit percentages and hemoglobin levels.15-17,19,20,23-25 No 
comparison with the literature could be made with regard to the correla-
tion that was found in group II between time-averaged maximum mean 
velocities and the reticulocyte percentages and fetal hemoglobin levels, 
since no such data is available in the literature.
There was a statistically significant difference in the time-averaged 
maximum mean velocities between the groups, such that it was greater 
in group I. This was probably because of the lower hemoglobin levels 
and lower hematocrit percentages in this group (P < 0.01).
Abnormalities were only observed in the middle cerebral artery, 
in both cerebral hemispheres, and these were found both in the pa-
tient with abnormal time-averaged maximum mean velocities and 
in the patients with conditional velocities. In 1992, Adams found 
that around 60% of the middle cerebral arteries were affected, and that 
the internal carotid arteries and anterior cerebral arteries were also 
affected.8,21
Our results emphasize the importance of performing transcranial 
Doppler on cases of sickle cell anemia. National studies in Brazil involv-
ing the use of transcranial Doppler on large numbers of patients with 
sickle cell disease are needed, given that some findings differ from data 
in the literature. It is still uncertain whether there is a determining factor 
that would explain such differences, or whether the sample size would 
explain these findings.
Transcranial Doppler does not seem to be a priority examination in 
relation to the other genotypes of sickle cell disease. Longitudinal fol-
low-up studies on patients with different sickle cell genotypes and their 
respective transcranial Doppler findings are needed to confirm this hy-
pothesis.
CONCLUSION
There was a low prevalence of abnormal Doppler results in patients 
with sickle-cell disease. Time-average maximum mean velocity was sig-
nificantly different between the genotypes and correlated with hemato-
logical characteristics.
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